BBLN earnings

Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone access to the event, w

Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable1, with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins2 in their first year Monthly Adjusted EBITDA of $(16.3) million for Q4 2022 beating guidance of $(18) million Adjusted EBITDA profitability expected in mid-2024, significantly earlier than previous guidance Commercial VBC revenue substantially increased with recent launch of Ambetter digital-first service across 6 states Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial an

Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Thursday, March 9, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone acc

Third quarter revenue grew 3.9x year-over-year to $288.9 million U.S. value-based care members grew by 171% year-over-year, including 285% growth in Medicare membership Adjusted EBITDA Margin of (18.8)% for the quarter (equivalent to $(18.1) million Adjusted EBITDA per month), a 45 percentage points improvement year-over-year, reflecting successful execution of cost reduction actions Partnering with Ambetter Health to provide digital-first value-based care services to Commercial Exchange members across 6 U.S. states from January 2023, as well as extending key partnership with Bupa in the UK to cover 2.3 million customers Members enrolled in integrated behavioral health programs exp

Babylon (NYSE:BBLN) ("Babylon" or the "Company") today announced it will host a conference call to review the Company's third quarter 2022 financial results in full on Thursday, November 10, 2022, at 8:00 AM Eastern Time. A press release announcing the third quarter results will be issued prior to the conference call on Thursday, November 10, 2022. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants, or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "

Second quarter revenue grew 4.6x year-over-year to $265.4 million U.S. value-based care members grew by 220% year-over-year Adjusted EBITDA Margin of (25.9)% for the quarter, a 60% improvement year-over-year Reiterating full year 2022 revenue guidance of $1.0 billion or greater and reiterating improved Adjusted EBITDA guidance of $(270.0) million Babylon Holdings Limited (NYSE:BBLN) ("Babylon"), one of the world's fastest-growing digital healthcare companies, today announced its financial and operating results for the second quarter ended June 30, 2022. "Babylon has once again delivered very strong results that demonstrate our continued momentum," said Ali Parsa, CEO and Founder o

Babylon (NYSE:BBLN) ("Babylon" or the "Company") today announced it will host a conference call to review the Company's second quarter 2022 financial results in full on Tuesday, August 9, 2022, at 5:00 PM Eastern Time. A press release announcing the second quarter results will be issued prior to the conference call on Tuesday, August 9, 2022. To participate in the live conference call and webcast, please dial (866) 682-6100 for U.S. participants, 0800 756 3429 for U.K. participants, or +1 862-298-0702 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me

First quarter 2022 revenue grew over 3.5x year-over-year to $266 million Increasing 2022 guidance for revenue to $1.0 billion or greater and updating Adjusted EBITDA guidance Adjusted EBITDA Margin of (27)% for the quarter, ahead of previous full-year 2022 guidance of (30)% U.S. value-based care members grew by 63% from Q4 2021 to a total of more than 270,000 members Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or "the Company"), one of the world's fastest growing digital healthcare companies, today announced its financial and operating results for the first quarter ended March 31, 2022. "Babylon has started 2022 with as much momentum as we finished 2021," said Ali Parsa, CEO a

Babylon (NYSE:BBLN) ("Babylon" or the "Company") will host a conference call on Thursday, May 12, 2022, at 8:00 AM Eastern Time to review the Company's first quarter 2022 financial results. A press release announcing the first quarter results will be issued prior to the conference call on Thursday, May 12, 2022. To participate in the Company's live conference call and webcast, please dial 877-407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants, or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant tel

2021 revenue grew over four times year-over-year to $323 million Monthly revenue in January 2022 exceeded $80 million Guidance for 2022 revenue to grow again almost another three times to $900 million to $1 billion Significant operational leverage, with Adjusted EBITDA as a percentage of Total revenue improving from (184)% in 2020 to (54)% in 2021, and projected to fall further to around (30)% in 2022; a six times reduction between 2020 and 2022 While growth continues at pace, 2022 focus will be on driving cost of care delivery margin improvements 2022 will also be a year of technology investment anchoring software licensing growth in 2023 Babylon Holdings Limited (NYSE:BBLN) (

Babylon (NYSE:BBLN) ("Babylon" or the "Company") will host a conference call on Thursday, March 10, 2022, at 8:00 AM Eastern Time to review the Company's fourth quarter 2021 financial results. A press release announcing the fourth quarter results will be issued prior to the conference call on Thursday, March 10, 2022. To participate in the Company's live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0800 756 3429 for U.K. participants, or +215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instan

Third quarter 2021 revenue grew 371% year-over-year to $74.5 million Signed contracts in H2 2021 in the US and UK added approximately 135,000 value-based care members Total contracts exceed $60 million monthly run-rate revenue once fully launched Contracted to serve, by the beginning of 2022, over 24 million people, with the technology platform and fee-based clinical services, and manage over 350,000 lives globally, making Babylon one of the largest value-based care providers Completed merger with Alkuri Global Acquisition Corp. and started trading on New York Stock Exchange, under the ticker symbol BBLN, with approximately $460 million of new capital raised Signed new collaborat

Babylon Holdings Limited (NYSE:BBLN) will host a conference call on Friday, November 12, 2021, at 8:00 AM Eastern Time to review the Company's fiscal third quarter 2021 financial results. A press release announcing the fiscal third quarter results will be issued on Friday, November 12, 2021, before the market opens. To participate in the Company's live conference call and webcast, please dial (877) 407-7994 for U.S. participants, or +1 (215) 268-9868 for international participants, or visit the "News & Events" section of https://ir.babylonhealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call. About Babylon Babylon